Head - Process Engineering, API R&D
Srividya Ramakrishnan earned her B.Tech from Indian Institute of Technology, Madras, and a Ph.D. from Princeton University in Chemical Engineering. With 20+ years of experience, she currently heads Process Engineering (Drug substance) at Dr. Reddy's Laboratories. She has presented her research at international conferences and has several publications and patents to her credit. She is also an ASQ-certified Six Sigma Black Belt.
Process Engineering Expert, API R&D
Suhas Jawlekar is a chemical engineer from ICT, Mumbai and has 17 years of experience in the process development and scale-up of APIs. He has worked closely on crystallization, polymorph development and particle engineering aspects of APIs. He currently leadsa teamfocused on particle engineering, scale-up and flow manufacturing technologies.
Characterisation Expert, Analytical R&D
Amuthan graduated with a master's degree from Anna University, followed by a doctorate degree in material science from EPFL (Swiss Federal Institute of Technology) from Lausanne, Switzerland. Amuthan is now working as a solid-state characterisation expert focused onthe area of structure property correlation and leads a team of engineers. He has more than 14 years of experience in the field of solid-state characterisation. His microscopy and scattering-based analytical skills are well-known through his scientific publication and presentation.
In the webinar, experts from Dr. Reddy's - Srividya Ramakrishnan head - process engineering, API R&D, Suhas Jawlekar, process engineering expert, API R&D, and Amuthan Ramar, characterization expert, analytical R&D address the importance of API particle size on formulation success that includes application of various particle engineering techniques and API powder properties, The structured problem-solving approach in achieving the right particle for formulations and Dr. Reddy's capabilities in particle engineering and characterization.
The first section of the webinar covers the relation between pharma API powder properties and drug product attributes – particle size distribution, API formulation, mechanical properties, morphology (drug product attributes), solid form, surface properties, followed by crystal morphology, size, and surface properties.
The next section of the webinar emphasizes particle engineering technologies spectrum, PAT tools to understand crystallization (PVM, FBRM, Raman, FTIR), and particle engineering capabilities – powder processing, API formulation process, control of PSD in slurry and downstream processing.
The concluding section of the webinar showcases the case studies and success stories related to API formulation – Flowability improvement, the outcome of crystallization design, dissolution performances, and case studies on customer requirements regarding the particle size, followed by orthogonal verification for robust and faster PSD methods and image analysis.
Want to learn more about our capabilities in particle engineering and characterization? Then feel free to contact our product experts by filling the form here https://api.drreddys.com/contact-us (Or) at firstname.lastname@example.org.
Nenhuma informação neste catálogo - incluindo qualquer referência a qualquer produto ou serviço - constitui uma oferta de venda ou deve ser interpretada como uma oferta de venda. Os produtos protegidos por patentes válidas não são oferecidos ou fornecidos para uso comercial. No entanto, as quantidades de pesquisa de tais produtos podem ser oferecidas para fins de submissão regulatória, onde quer que existam tais isenções regulatórias. Os compradores devem fazer sua avaliação independente do cenário de patentes para seus respectivos mercados e serão responsáveis por todas as responsabilidades relacionadas à patente. Os produtos protegidos por patentes válidas na Índia não estão disponíveis para uso comercial, mas estariam disponíveis para os propósitos da Seção 107A.